De Lillo A, Pathak GA, Low A, De Angelis F, Abou Alaiwi S, Miller EJ, Fuciarelli M, Polimanti R
This approval was based on the STEP (Semaglutide Treatment Effect in People with obesity) clinical trial program, which enrolled over 4,500 participants
Selection of OS-modulating agents Although the various antioxidants and pro-oxidants listed in Table 2 have demonstrated potential for regulating OS and inhibiting uterine fibroids, the complexity of selecting OS modulators for clinical translation manifests across multiple levels
Constitutive immune mechanisms: mediators of host defence and immune regulation
5alpha-androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult